Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 694, Issue 1-2, 2010, Pages 39-44

  de Verdier, Petra J ^a   Sanyal, Somali ^a,b   Bermejo, Justo Lorenzo ^c,f   Steineck, Gunnar ^b,d   Hemminki, Kari ^c,e   Kumar, Rajiv ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Haplotypes; Polymorphisms; Urinary bladder cancer; XPC

Indexed keywords

XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78649451471     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.09.003     Document Type: Article

References (24)

1. Scelo G., Brennan P. The epidemiology of bladder and kidney cancer. Nat. Clin. Pract. Urol. 2007, 4:205-217.
2. Vineis P., Marinelli D., Autrup H., Brockmoller J., Cascorbi I., Daly A.K., Golka K., Okkels H., Risch A., Rothman N., Sim E., Taioli E. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1249-1252.
3. Cohen S.M., Shirai T., Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl. 2000, 105-115.
4. Ji J., Granstrom C., Hemminki K. Occupation and bladder cancer: a cohort study in Sweden. Br. J. Cancer 2005, 92:1276-1278.
5. Zeegers M.P., Kellen E., Buntinx F., van den Brandt P.A. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J. Urol. 2004, 21:392-401.
6. de Laat W.L, Jaspers N.G., Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 1999, 13:768-785.
7. Friedberg E. How nucleotide excision repair protects against cancer. Nat. Rev./Cancer 2001, 1:22-33.
8. Yokoi M., Masutani C., Maekawa T., Sugasawa K., Ohkuma Y., Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem. 2000, 275:9870-9875.
9. Khan S.G., Muniz-Medina V., Shahlavi T., Baker C.C., Inui H., Ueda T., Emmert S., Schneider T.D., Kraemer K.H. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002, 30:3624-3631.
10. Chavanne F, Broughton B.C., Pietra D., Nardo T., Browitt A., Lehmann A.R., Stefanini M. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 2000, 60:1974-1982.
11. Khan S.G., Metter E.J., Tarone R.E., Bohr V.A., Grossman L., Hedayati M., Bale S.J., Emmert S., Kraemer K.H. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis 2000, 21:1821-1825.
12. Sanyal S., De Verdier P.J., Steineck G., Larsson P., Onelov E., Hemminki K., Kumar R. Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol. 2007, 46:31-41.
13. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkstrom H., Larsson P., Kumar R., Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004, 25:729-734.
14. Larsson P., Wijkstrom H., Thorstenson A., Adolfsson J., Norming U., Wiklund P., Onelov E., Steineck G. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand. J. Urol. Nephrol. 2003, 37:195-201.
15. Wada T., Louhelainen J., Hemminki K., Adolfsson J., Wijkstrom H., Norming U., Borgstrom E., Hansson J., Sandstedt B., Steineck G. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade [In Process Citation]. Clin. Cancer Res. 2000, 6:610-615.
16. Stern M.C., Lin J., Figueroa J.D., Kelsey K.T., Kiltie A.E., Yuan J.M., Matullo G., Fletcher T., Benhamou S., Taylor J.A., Placidi D., Zhang Z.F., Steineck G., Rothman N., Kogevinas M., Silverman D., Malats N., Chanock S., Wu X., Karagas M.R., Andrew A.S., Nelson H.H., Bishop D.T., Sak S.C., Choudhury A., Barrett J.H., Elliot F., Corral R., Joshi A.D., Gago-Dominguez M., Cortessis V.K., Xiang Y.B., Gao Y.T., Vineis P., Sacerdote C., Guarrera S., Polidoro S., Allione A., Gurzau E., Koppova K., Kumar R., Rudnai P., Porru S., Carta A., Campagna M., Arici C., Park S.S., Garcia-Closas M. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res. 2009, 69:6857-6864.
17. Zhu Y, Lai M., Yang H., Lin J., Huang M., Grossman H.B., Dinney C.P., Wu X. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 2007, 28:698-703.
18. Gozukara E.M., Khan S.G., Metin A., Emmert S., Busch D.B., Shahlavi T., Coleman D.M., Miller M., Chinsomboon N., Stefanini M., Kraemer K.H. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J. Invest. Dermatol. 2001, 117:197-204.
19. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., Kiltie A.E. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br. J. Cancer 2005, 92:2262-2265.
20. Lee G.Y, Jang J.S., Lee S.Y., Jeon H.S., Kim K.M., Choi J.E., Park J.M., Chae M.H., Lee W.K., Kam S., Kim I.S., Lee J.T., Jung T.H., Park J.Y. XPC polymorphisms and lung cancer risk. Int. J. Cancer 2005, 115:807-813.
21. Garcia-Closas M., Malats N., Real F.X., Welch R., Kogevinas M., Chatterjee N., Pfeiffer R., Silverman D., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Chanock S., Yeager M., Rothman N. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:536-542.
22. Qiao Y., Spitz M.R., Shen H., Guo Z., Shete S., Hedayati M., Grossman L., Mohrenweiser H., Wei Q. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002, 23:295-299.
23. Blankenburg S., Konig I.R., Moessner R., Laspe P., Thoms K.M., Krueger U., Khan S.G., Westphal G., Berking C., Volkenandt M., Reich K., Neumann C., Ziegler A., Kraemer K.H., Emmert S. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005, 26:1085-1090.
24. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Voigt L.F., Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2524-2530.